October 25, 2020

$MRTX Mirati Therapeutics Awesome Clinical Data

MRTX stock moved higher on October 23, 2020, after the company released awesome anti-tumor activity from its clinical trial. Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced

Biotechnology

October 16, 2020

Regeneron Pharmaceuticals $REGN Stock Up On CHMP Approval of Dupixent

REGN stock rose in morning trade on October 16, 2020, after the company announced CHMP recommended approval for Dupixent. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European

Biotechnology

Coronavirus

October 13, 2020

$JNJ $LLY $AZN Eli Lilly and Johnson & Johnson Paused Coronavirus Vaccine Programs

A government-sponsored clinical trial testing a COVID-19 antibody treatment made by the Eli Lilly (LLY) has been paused because of a "potential safety concern," according to The New York Times'

Analysts Activity

Biotechnology

Coronavirus

October 8, 2020

$REGN Regeneron Requests Emergency Approval for COVID-19 Antibody Treatment

Benchmark analyst Aydin Huseynov said his comparison of the SARS-CoV2 antibody data reported by Eli Lilly (LLY) to the antibody data of Regeneron (REGN) leads him to conclude that Regeneron's

Biotechnology

Coronavirus

October 6, 2020

VIR, GSK begin Phase 3 Trial for Covid-19 Antibody Drug

Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care

Biotechnology

Coronavirus

October 3, 2020

$REGN Using Regeneron Cocktail To Treat Trump

We now know that Regeneron has the best coronavirus treatment on the market. Forget about remdesivir with dexamethasone, you want REGN-COV2 like immediately. REGN-COV2 reduces the viral load. There are only

Biotechnology

Coronavirus

October 2, 2020

$REGN Stock Up In After-hours On COVID-19 Treatment Given to President Trump

Regeneron Pharmaceuticals confirmed that, as announced by the White House Press Secretary, Regeneron provided a single 8 gram dose of REGNCOV2, a cocktail of two monoclonal antibodies, for use by

Biotechnology

September 30, 2020

$BIIB $SRPT Biotech analyst discusses Her Top Stock Picks

Piper Sandler analyst Tyler Van Buren maintains an Overweight rating and $200 price target on shares of Sarepta after the company reported at the World Muscle Society virtual congress that

Biotechnology

Coronavirus

September 28, 2020

Tonix Pharmaceuticals $TNXP Stock Explodes In After-hours On Purchase of Facility

TNXP stock exploded higher in after-hours trading on September 28, 2020, after the company announced the purchase of a 40,000 square foot facility in Massachusetts to house its new Advanced

Biotechnology

Dark Pool Trading

September 27, 2020

Alexion Pharmaceuticals $ALXN Stock Dark Pool Trade

An unusual dark pool trade was detected in ALXN stock on September 25, 2020. On September 25, 2020, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that Japan’s Ministry of Health, Labour and Welfare

« Older Articles